Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $163.1000 (-1.07%) ($161.9500 - $164.6100) on Thu. Dec. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 62 | Latest Price | $163.1000(-1.07%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XBI(11%) XLV(10%) DIA(8%) MCHI(8%) SPLV(8%) | Factors Impacting ABBV price | ABBV will decline at least -0.77% in a week (0% probabilities). VIXM(-9%) IWN(-8%) JETS(-7%) UUP(-6%) ONLN(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | -1.3 () | Intraday Trend | -0.7% | | | |
|
5 Day Moving Average | $164.23(-0.69%) | 10 Day Moving Average | $164.39(-0.78%) | 20 Day Moving Average | $161.52(0.98%) | To recent high | -1.7% | To recent low | 21.5% | Market Cap | $287.755b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |